Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$33.1B
This Quarter Return
+9.46%
1 Year Return
+13.62%
3 Year Return
+68.72%
5 Year Return
+148.95%
10 Year Return
+371.3%
AUM
$41.2B
AUM Growth
+$41.2B
(+8.6%)
Cap. Flow
-$74.9M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
737
New
74
Increased
255
Reduced
308
Closed
75
Top Buys
| 1 |
IBM
IBM
|
$257M |
| 2 |
Exxon Mobil
XOM
|
$219M |
| 3 |
RTX Corp
RTX
|
$203M |
| 4 |
Chevron
CVX
|
$188M |
| 5 |
Qualcomm
QCOM
|
$175M |
Top Sells
| 1 |
Pfizer
PFE
|
$641M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$385M |
| 3 |
Microsoft
MSFT
|
$210M |
| 4 |
McDonald's
MCD
|
$185M |
| 5 |
Merck
MRK
|
$181M |
Sector Composition
| 1 | Technology | 23.11% |
| 2 | Healthcare | 22.91% |
| 3 | Consumer Staples | 22.12% |
| 4 | Energy | 7.11% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class C
GOOG
$2.58T
| $1.93B | 4.69% | 1,724,121 -343,370 | -17% | -$385M |
|
|
2
Microsoft
MSFT
$3.77T
| $1.86B | 4.51% | 49,690,399 -5,605,586 | -10% | -$210M |
|
3
Oracle
ORCL
$635B
| $1.83B | 4.45% | 47,906,184 -1,535,787 | -3% | -$58.8M |
|
4
Johnson & Johnson
JNJ
$427B
| $1.81B | 4.4% | 19,775,624 -1,434,621 | -7% | -$131M |
|
|
5
Chevron
CVX
$324B
| $1.7B | 4.12% | 13,580,378 +1,507,602 | +12% | +$188M |
|
|
6
IBM
IBM
$227B
| $1.69B | 4.1% | 8,999,935 +1,368,118 | +18% | +$257M |
|
7
Coca-Cola
KO
$297B
| $1.59B | 3.85% | 38,425,687 -1,973,083 | -5% | -$81.5M |
|
8
Procter & Gamble
PG
$368B
| $1.59B | 3.85% | 19,470,736 +55,763 | +0.3% | +$4.54M |
|
9
Philip Morris
PM
$260B
| $1.49B | 3.61% | 17,066,193 +855,976 | +5% | +$74.6M |
|
10
Walmart
WMT
$774B
| $1.14B | 2.75% | 14,425,556 -911,518 | -6% | -$71.7M |
|
11
Cisco
CSCO
$274B
| $1.08B | 2.63% | 48,184,364 +6,567,159 | +16% | +$147M |
|
12
PepsiCo
PEP
$204B
| $1.01B | 2.46% | 12,232,738 -1,320,764 | -10% | -$110M |
|
|
ESRX
13
DELISTED
Express Scripts Holding Company
ESRX
| $970M | 2.35% | 13,804,543 -286,597 | -2% | -$20.1M |
|
|
14
Pfizer
PFE
$141B
| $821M | 1.99% | 26,803,828 -20,922,283 | -44% | -$641M |
|
15
3M
MMM
$82.8B
| $778M | 1.89% | 5,550,325 +331,911 | +6% | +$46.6M |
|
|
16
Exxon Mobil
XOM
$487B
| $771M | 1.87% | 7,621,912 +2,162,025 | +40% | +$219M |
|
|
17
Qualcomm
QCOM
$173B
| $718M | 1.74% | 9,674,985 +2,352,731 | +32% | +$175M |
|
18
Apple
AAPL
$3.45T
| $679M | 1.65% | 1,209,959 +223,220 | +23% | +$125M |
|
19
Colgate-Palmolive
CL
$67.9B
| $672M | 1.63% | 10,304,826 -769,610 | -7% | -$50.2M |
|
20
Abbott
ABT
$231B
| $619M | 1.5% | 16,154,651 +124,422 | +0.8% | +$4.77M |
|
21
Medtronic
MDT
$119B
| $585M | 1.42% | 10,186,365 +62,283 | +0.6% | +$3.57M |
|
22
UnitedHealth
UNH
$281B
| $577M | 1.4% | 7,664,565 +1,055,162 | +16% | +$79.5M |
|
|
23
McDonald's
MCD
$224B
| $569M | 1.38% | 5,860,005 -1,902,906 | -25% | -$185M |
|
|
24
Merck
MRK
$210B
| $484M | 1.17% | 9,665,336 -3,625,772 | -27% | -$181M |
|
25
Bristol-Myers Squibb
BMY
$96B
| $475M | 1.15% | 8,939,857 +570,925 | +7% | +$30.3M |
|